by Roche Diagnostics with support from Story Worldwide
by Sanofi
by Boehringer Ingelheim with support from infill Kommunikation GmbH
by Lundbeck
by Teva UK Limited with support from Strategen
by Lundbeck
There is a wide variation in Parkinson’s disease (PD) services across the UK which means that rates of diagnosis and review of medication differ drastically. NHS reforms have bought with them a need for local services to deliver the best quality service to remain competitive.
By supporting the creation of a series of tools to help physicians and payers develop an Integrated Care Pathway (ICP) for PD, as well as piloting the creation of an ICP in the Sunderland area, Lundbeck has been able to help achieve the following outcomes:
This was a well-focused initiative, which was very innovative in terms of business intelligence. A very well thought out pilot project that delivered success. We look forward to seeing this when it has been scaled up with more customer feedback.
Entry deadline | 26 August 2022 |
Extended entry deadline | 2 September 2022* *additional fee applies |
Judging Day | 6 October 2022 |
Company/Team of the Year Interviews | 21 October 2022 |
PMEA Event | 23 November 2022 |